Industry Pushes For Biosimilars Approval Process; Some IGOs Take Notice 24/02/2009 by Kiernan A. Murphy for Intellectual Property Watch and Kaitlin Mara for Intellectual Property Watch Leave a Comment Key players in the biotechnology industry are leading an effort to obtain global approval processes for generic biological medicines, which experts say could provide cheaper access to costly but widely prescribed and promising treatments.
欧盟有关知识产权的强硬规定被视为对贫困国家医药获得的威胁 24/02/2009 by David Cronin for Intellectual Property Watch Leave a Comment 布鲁塞尔 – 全球公共卫生活跃分子声称，欧盟执意要在一系列自由贸易协议中添加有关医药专利的强硬规定将会妨害发展中国家获得医药。
لأحكام التجارية القوية للاتحاد الأوروبي حول الملكية الفكرية تعتبر تهديدا على نفاذ البلدان الفقيرة إلى الأدوية 24/02/2009 by David Cronin for Intellectual Property Watch Leave a Comment ابروكسل- إن الجهود التي يبذلها الاتحاد الأوروبي لإدراج أحكام حول براءات المستحضرات الصيدلانية في سلسلة من اتفاقات التجارة الحرة التي يتفاوض حولها قد تشكل تهديدا على إمكانية الحصول على الأدوية في البلدان النامية، على حد قول الناشطين في مجال الصحة العامة على الصعيد العالمي.
Des dispositions renforçant la propriété intellectuelle dans certains accords de l’UE menacent l’accès aux médicaments dans les pays pauvres 24/02/2009 by David Cronin for Intellectual Property Watch Leave a Comment BRUXELLES – Selon certains activistes de la santé publique mondiale, les efforts de l’Union européenne (UE) pour intégrer des dispositions sur les brevets pharmaceutiques dans un certain nombre d’accords de libre échange en cours de négociation pourraient mettre en péril l’accès aux médicaments dans les pays en développement.
Las estrictas disposiciones comerciales de la UE sobre PI representan una amenaza para el acceso de los países pobres a los medicamentos 24/02/2009 by David Cronin for Intellectual Property Watch 1 Comment BRUSELAS- Los esfuerzos de la Unión Europea para introducir disposiciones firmes en materia de patentes farmacéuticas en una serie de acuerdos de libre comercio que está negociando podrían poner en peligro el acceso a los medicamentos en los países en desarrollo, según han afirmado activistas de la salud pública a nivel mundial.
French Legislature Puts Finishing Touches On Ambitious File-Sharing Law 23/02/2009 by Bruce Gain for Intellectual Property Watch 5 Comments French legislators are putting the final touches on controversial legislation that will likely lead to the most governmentally-proactive law intended to curb illegal file sharing among any other European Union member state.
International Health Groups Warn WHO, WTO On Medicines Seizures 21/02/2009 by William New, Intellectual Property Watch 7 Comments Leading international public health advocates have sent letters to the heads of the World Health Organization and World Trade Organization calling on them to act to prevent possible circumvention of international trade rules for intellectual property rights relating to shipments of legal generic drugs bound for developing countries.
ISP Liability, Copyright Term Extension Key IP Issues For Europe This Year 18/02/2009 by Dugie Standeford for Intellectual Property Watch Leave a Comment The effort to tackle digital piracy is likely to remain the most contentious intellectual property issue in Europe this year. It will be joined by debates on copyright term extension, IP provisions in trade agreements, and an ongoing discussion of patent policy in Europe.
Strong EU Trade Provisions On IP Seen As Threat To Poor Nations’ Medicines Access 18/02/2009 by David Cronin for Intellectual Property Watch 2 Comments BRUSSELS – Efforts by the European Union to insert strong provisions on pharmaceutical patents in a series of free trade agreements it is negotiating could imperil access to medicines in developing countries, global public health activists have alleged. As part of trade talks being conducted with India, Colombia, Peru and a regional grouping in south-east Asia, EU officials have proposed that drug-makers should benefit from a robust intellectual property regime. National regulatory authorities in the countries concerned would be prevented for lengthy periods from using data provided by a company that holds a drug patent in order to authorise a generic version of that medicine.
Estalla la preocupación por el sistema de la OMC y el transporte de medicamentos; se reaviva el debate sobre los ADPIC 10/02/2009 by William New, Intellectual Property Watch Leave a Comment Los Embajadores de Brasil e India ante la Organización Mundial del Comercio (OMC) han acusado a otros miembros de la OMC de no tener fundamentos para bloquear el transporte legal de medicamentos genéricos sobre la base de posibles conflictos de derechos de propiedad intelectual (DPI) en el país de tránsito, y advirtieron que los ejemplos […]